These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors. Gilbert DC; Van As NJ; Huddart RA Expert Rev Anticancer Ther; 2009 Feb; 9(2):223-33. PubMed ID: 19192960 [TBL] [Abstract][Full Text] [Related]
25. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C; J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987 [TBL] [Abstract][Full Text] [Related]
26. Re: Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors. Schatte EC; Lerner SP J Urol; 2000 Nov; 164(5):1670. PubMed ID: 11203071 [No Abstract] [Full Text] [Related]
27. Management of stage I nonseminomatous germ-cell tumors. Thomas J; Aleman M; Dreicer R; Klein EA Semin Urol Oncol; 2002 Nov; 20(4):220-6. PubMed ID: 12489053 [TBL] [Abstract][Full Text] [Related]
28. Nonseminomatous germ cell tumor of the testis. Matthews GJ; Mordente J; Lifson B Urology; 1997 Jan; 49(1):117-8. PubMed ID: 9000199 [No Abstract] [Full Text] [Related]
37. [Treatment of germ cell tumors at the threshold of the third millennium]. Géczi L; Biron P; Droz JP Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261 [TBL] [Abstract][Full Text] [Related]
38. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity. Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957 [TBL] [Abstract][Full Text] [Related]
39. [Update on about testicular cancer]. Houlgatte A; Dourthe LM; Bernard O Bull Cancer; 2002 Jan; 89(1):47-56. PubMed ID: 11847026 [TBL] [Abstract][Full Text] [Related]
40. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility. Cooper DE; L'esperance JO; Christman MS; Auge BK J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]